Immunicom, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy has the potential to allow the body’s natural immune system to directly attack the cancer while enhancing the effects of other cancer treatments which may be used concurrently. 

At Immunicom we are reimagine how healing should be.

Sign up for free to view info

Email Format Employee directory